Aprecia offers commercial-scale production systems designed to accelerate clinical development and optimize commercial success. Our industry-leading 3DP formulation and manufacturing platforms transform drug development and delivery, meeting the unprecedented demand for complex and patient-friendly dosage forms. Aprecia joined with MIT Technology to build groundbreaking 3DP pharmaceutical technology with a mission towards advancing personalized medicine. With the first-of-its-kind innovations, Aprecia enables NDAs, extends product lifestyles, and accelerates clinical development. · Powder-based 3DP techniques use the widest set of ready materials compared to other additive manufacturing techniques. · The Binder Jetting technique provides the most flexibility when creating pharmaceutical formulations. · Aprecia is the first and only company in the world to obtain regulatory approval for a 3DP pharmaceutical product and utilized the MIT invented Binder Jetting technique to realize that feat. This transformed the use of 3DP from rapid prototyping in a laboratory setting to at scale production in a cGMP environment. Aprecia is a sister company of PRASCO The Leader In Authorized Generics and Trusted Pharmaceutical Partner Aprecia is poised to revolutionize pharmaceutical manufacturing through precision medicine and distributed manufacturing.